Infographic Summary
Global Guillain-Barre Syndrome (GBS) Therapeutics Market size is forecast to increase from $861.81 Million in 2026 to $1405 Million in 2034 at a CAGR of 6.3% between 2026 and 2034.
Global Guillain-Barre Syndrome (GBS) Therapeutics Market size is forecast to increase from $861.81 Million in 2026 to $1405 Million in 2034 at a CAGR of 6.3% between 2026 and 2034.
Global Guillain-Barre Syndrome (GBS) Therapeutics Market size is forecast to increase from $861.81 Million in 2026 to $1405 Million in 2034 at a CAGR of 6.3% between 2026 and 2034.